Atrás
Rango del Día
$23.99
$25.00
Rango de 52 Semanas
$8.58
$25.44
Volumen
883,520
Promedio 50D / 200D
$21.50
/
$16.47
Cierre Anterior
$24.23
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Healthcare (626 pares)
| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | -7.4 | 0.4 |
| P/B | 32.9 | 2.9 |
| ROE % | -161.8 | 3.7 |
| Net Margin % | -165.6 | 3.8 |
| Rev Growth 5Y % | 5.4 | 10.0 |
| D/E | 5.4 | 0.2 |
Puntos Clave
Revenue grew 5.39% annually over 5 years — modest growth
Debt/Equity of 5.36 — high leverage
Negative free cash flow of -323.17M
PEG of 0.55 suggests growth is underpriced
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 622.45%
Capital efficient — spends only 0.11% of revenue on capex
Crecimiento
Revenue Growth (5Y)
5.39%
Revenue (1Y)627.84%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Calidad
Return on Equity
-161.82%
ROIC-49.82%
Net Margin-165.60%
Op. Margin-158.45%
Seguridad
Debt / Equity
5.36
Current Ratio4.40
Interest Coverage-8.08
Valoración
P/E Ratio
-7.44
P/B Ratio32.88
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 627.84% | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 5.39% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 172.35M | Net Income (TTM) | -285.42M |
| ROE | -161.82% | ROA | -53.88% |
| Gross Margin | 95.96% | Operating Margin | -158.45% |
| Net Margin | -165.60% | Free Cash Flow (TTM) | -323.17M |
| ROIC | -49.82% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 5.36 | Current Ratio | 4.40 |
| Interest Coverage | -8.08 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -7.44 | P/B Ratio | 32.88 |
| P/S Ratio | 12.33 | PEG Ratio | 0.55 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 2.12B | Enterprise Value | 2.34B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 172.35M | 23.68M | 0.0 | 0.0 | 139.71M |
| Net Income | -285.42M | -318.76M | -209.36M | -149.34M | 24.93M |
| EPS (Diluted) | -3.30 | -3.73 | -2.98 | -2.46 | 0.48 |
| Gross Profit | 165.38M | 22.85M | 0.0 | 0.0 | 139.71M |
| Operating Income | -273.08M | -339.67M | -229.95M | -151.76M | 26.22M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 529.71M | 724.82M | 612.88M | 497.24M | 449.66M |
| Total Liabilities | 465.08M | 436.69M | 58.68M | 29.79M | 41.29M |
| Shareholders' Equity | 64.63M | 288.12M | 554.20M | 467.45M | 408.37M |
| Total Debt | 346.48M | 345.74M | 1.64M | 1.16M | 20.97M |
| Cash & Equivalents | 134.93M | 154.08M | 295.39M | 74.36M | 221.97M |
| Current Assets | 528.08M | 603.06M | 580.88M | 489.79M | 448.40M |
| Current Liabilities | 120.12M | 103.55M | 58.10M | 29.07M | 20.68M |